SANTOSH C. SINHA,TODD M. HEIDELBAUGH,SMITA S. BHAT,KEN CHOW
申请号：
BRPI0906927
公开号：
BRPI0906927A2
申请日:
2009.01.13
申请国别(地区):
BR
年份:
2015
代理人:
摘要：
A compound having selective modulating activity at the alpha 2B and or alpha 2C adrenergic receptor subtypes is represented by the general Formula (1): wherein R1-R6 is independently selected from the group consisting of H, C1-6 alkyl, halogen, CH2OH, CH2N(R7)2) CH2CN, C(O)R8, CF3, and aryl； wherein R7 is H or C1-6 alkyl； and R8 is H, C1-6 alkyl or aryl. The compounds of Formula (1) can be incorporated in pharmaceutical compositions and used in methods of treatment of alpha 2 receptor mediated diseases and conditions.
